Rmb Capital Management Lowers stake in Cooper Companies Inc (COO)

Cooper Companies Inc (COO) : Rmb Capital Management reduced its stake in Cooper Companies Inc by 16.55% during the most recent quarter end. The investment management company now holds a total of 141,137 shares of Cooper Companies Inc which is valued at $25,588,138 after selling 27,997 shares in Cooper Companies Inc , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.Cooper Companies Inc makes up approximately 1.76% of Rmb Capital Management’s portfolio.

Other Hedge Funds, Including , Swiss National Bank boosted its stake in COO in the latest quarter, The investment management firm added 9,400 additional shares and now holds a total of 135,700 shares of Cooper Companies Inc which is valued at $24,602,410. Cooper Companies Inc makes up approx 0.04% of Swiss National Bank’s portfolio. Hermes Investment Management Ltd added COO to its portfolio by purchasing 121,123 company shares during the most recent quarter which is valued at $21,506,600. Cooper Companies Inc makes up approx 0.42% of Hermes Investment Management Ltd’s portfolio.Ls Investment Advisors boosted its stake in COO in the latest quarter, The investment management firm added 1,059 additional shares and now holds a total of 2,868 shares of Cooper Companies Inc which is valued at $509,242. Cooper Companies Inc makes up approx 0.03% of Ls Investment Advisors’s portfolio.Ibm Retirement Fund reduced its stake in COO by selling 50 shares or 1.03% in the most recent quarter. The Hedge Fund company now holds 4,801 shares of COO which is valued at $852,466. Cooper Companies Inc makes up approx 0.03% of Ibm Retirement Fund’s portfolio.

Cooper Companies Inc closed down -1.58 points or -0.86% at $181.29 with 1,17,219 shares getting traded on Monday. Post opening the session at $182.42, the shares hit an intraday low of $180.78 and an intraday high of $182.715 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Cooper Companies Inc reported $2.05 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jun 2, 2016. Analyst had a consensus of $1.92. The company had revenue of $484.80 million for the quarter, compared to analysts expectations of $463.97 million. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.72 EPS.

Many Wall Street Analysts have commented on Cooper Companies Inc. Company shares were Reiterated by Stifel on Jun 30, 2016 to “Buy”, Firm has raised the Price Target to $ 195 from a previous price target of $180 .Company shares were Reiterated by Jefferies on Jun 3, 2016 to “Buy”, Firm has raised the Price Target to $ 190 from a previous price target of $175 .

The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch SeeClear and Mobius.

Leave a Reply

Cooper Companies Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cooper Companies Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.